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Joint single-cell DNA accessibility and protein
epitope profiling reveals environmental regulation
of epigenomic heterogeneity
Xingqi Chen1,7, Ulrike M. Litzenburger1, Yuning Wei1, Alicia N. Schep1,2,3, Edward L. LaGory4,
Hani Choudhry5, Amato J. Giaccia4, William J. Greenleaf 1,2,3 & Howard Y. Chang 1,6
Here we introduce Protein-indexed Assay of Transposase Accessible Chromatin with
sequencing (Pi-ATAC) that combines single-cell chromatin and proteomic profiling. In con-
junction with DNA transposition, the levels of multiple cell surface or intracellular protein
epitopes are recorded by index flow cytometry and positions in arrayed microwells, and then
subject to molecular barcoding for subsequent pooled analysis. Pi-ATAC simultaneously
identifies the epigenomic and proteomic heterogeneity in individual cells. Pi-ATAC reveals a
casual link between transcription factor abundance and DNA motif access, and deconvolute
cell types and states in the tumor microenvironment in vivo. We identify a dominant role for
hypoxia, marked by HIF1α protein, in the tumor microvenvironment for shaping the regulome
in a subset of epithelial tumor cells.
DOI: 10.1038/s41467-018-07115-y OPEN
1 Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA 94305, USA. 2Dept of Genetics, Stanford University, Stanford, CA 94305, USA.
3 Department of Applied Physics, Stanford University, Stanford, CA 94305, USA. 4Division of Radiation and Cancer Biology, Department of Radiation
Oncology, Stanford University, Stanford, CA 94305, USA. 5Department of Biochemistry, Cancer Metabolism and Epigenetic Unit, Faculty of Science, Cancer
and Mutagenesis Unit, King Fahd Center for Medical Research, King Abdulaziz University, Jeddah 22252, Saudi Arabia. 6 Howard Hughes Medical Institute,
Stanford University, Stanford, CA 94305, USA. 7Present address: Department of Cell and Molecular Biology, Karolinska Institutet, 17177 Solna, Sweden.
These authors contributed equally: Xingqi Chen, Ulrike M. Litzenburger, Yuning Wei. Correspondence and requests for materials should be addressed to
U.M.L. (email: litzenbu@stanford.edu) or to H.Y.C. (email: howchang@stanford.edu)
NATURE COMMUNICATIONS |          (2018) 9:4590 | DOI: 10.1038/s41467-018-07115-y | www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
Cell-to-cell variation is a universal feature that impactsnormal development and human disease1. While recentadvances in single-cell research have improved our ability
to document cellular phenotypic variation1, the fundamental
mechanisms that generate variability from identical DNA
sequences remain elusive. Uncovering the molecular mechanism
behind cellular heterogeneity would be helpful in clinical diag-
nosis, understanding the basic mechanism of developmental
disorders, molecular basis of drug resistance in cancer, and
therapy of human diseases in the long term. In the last decades,
studies revealed that chromatin structure is a main player reg-
ulating gene expression, and that it is tightly linked to hetero-
geneity in transcription and phenotype2. To fully understand the
molecular mechanism determining cell-to-cell heterogeneity, it is
essential to define the chromatin landscape in each individual cell.
Recent advances in single-cell chromatin technologies revealed
the variation of chromatin organization across individual cells3–5.
These technologies demonstrate that accessibility variance is
associated with specific transcription factors (TFs) and provide
new insight into cellular variation of the “regulome”3. In these
approaches, cells are randomly selected for next-generation
sequencing and the cellular variation is decoded using compu-
tational de-convolution. Thus, using available technologies, we
only interpret the cellular variation and define subtypes indirect
by clustering, dimensionality reduction such as principal com-
ponent analysis method or projection onto a bulk scaffold.
Therefore, until now, the cell-to-cell epigenetic variation cannot
unambiguously be linked to the cellular phenotype or cell state.
Staining of proteins for specific cell types and cell stages is helpful
to indicate the cellular phenotype, for example, phosphorylated
focal adhesion kinase for a migratory cell state6 or Hypoxia
Inducible Factor 1 alpha (HIF1α) staining for cells in a hypoxic
environment. Although an extensive effort was put on increasing
throughput of these single-cell technologies2,4, the direct linkage
of cellular phenotype to the chromatin variation of individual
cells remains largely ignored.
Here, we describe a novel single-cell approach, protein-indexed
single-cell assay of transposase accessible chromatin-seq (Pi-
ATAC), in which we index and quantify protein expression using
index fluorescence-activated cell sorting (FACS) and enumerate
the accessible DNA elements of the same individual cell. The
combination of protein and epigenetic profile allows us to directly
link the cellular phenotype and environment to the chromatin
variation of individual cells. We applied Pi-ATAC to primary,
heterogeneous mouse breast tumors and characterized cell states
of tumor-infiltrating immune cells, as well as tumor cells simul-
taneously. In addition, we link epigenetic variability of tumor cells
to the hypoxic tumor microenvironment. The described method
allows to unbiasedly combine single-cell ATAC-seq with tradi-
tional FACS and therefore would be relevant to wide range of
biology groups.
Results
Development of Pi-ATAC method. We were motivated to
develop Pi-ATAC to provide two innovative advances for mul-
tiomics. First, Pi-ATAC enables intracellular protein analysis and
DNA accessibility from the same individual cell. We and others
had used conventional flow cytometry with cell surface markers
to isolate different cell types7,8. In Pi-ATAC, we have developed a
new method to crosslink cells and perform intracellular protein
analysis (including in the nucleus) jointly with single-cell ATAC-
seq. Thus, Pi-ATAC opens the door for >85%9 of the proteome
for single-cell multiomics.
Second, in Pi-ATAC, we accomplish the indexing of both
protein epitope levels and DNA regulatory landscape. Prior
application of flow cytometry to ATAC-seq involved gates, where
many cells within a wide range of protein levels are lumped
together. This is a far cry from Pi-ATAC, where the level of
individual protein epitopes in each cell is precisely enumerated.
Pi-ATAC works on fixed cells or tissue, which then can be
stored prior to tagmentation, allowing collection of rare cells and
pooling across multiple experiments. As a result, investigators can
prospectively focus their sequencing power on rare but interesting
cells. In more detail, in Pi-ATAC cells or tissue are first fixed
using paraformaldehyde (PFA), then gently dissociated and
permeabilized (Methods), followed by antibody staining against
protein epitopes of interest. As the cells are already fixed and
permeabilized, intracellular as well as intranuclear staining are
possible. Then, cells are transposed in bulk. The reaction is
stopped by addition of EDTA, without any purification step. As
single cells are sorted into individual wells containing the reverse
crosslinking buffer (Methods), fluorescence intensities of anti-
bodies against protein epitopes of interest are recorded and
assigned to the position of sorted cells. After reverse crosslinking,
libraries are prepared by barcoding PCR (Fig. 1a).
The reverse crosslinking buffer used in Pi-ATAC was specially
developed to be compatible with the barcoding PCR step. In
ATAC-see, tagmentation is also performed on fixed cells, together
with either intranuclear or cytoplasmic protein staining10.
However, DNA Taq polymerase is not compatible with sodium
dodecyl sulfate (SDS) included in the traditional reverse cross-
linking buffer11. Hence, we developed a new reverse crosslinking
(Methods), in which the DNA Taq polymerase is not inhibited.
First, we confirmed the functionality of the new reverse
crosslinking buffer followed directly by PCR without purification
in bulk ATAC-seq libraries. Quality of the bulk ATAC-seq
libraries prepared using the new reverse crosslinking either with
or without DNA purification is comparable to the previous
protocol of reverse crosslinking buffer with purification, including
(i) enrichment of fragments at transcription start sites, (ii)
fragment amount observed in open chromatin peaks identified,
and (iii) coverage on both gene promoters and distal elements
(Supplementary Figure 1a-e). Together, we conclude that the new
reverse crosslinking buffer is compatible with the PCR reaction
for library preparation in Pi-ATAC.
Validation of Pi-ATAC workflow in single cells. We next vali-
dated the workflow and accuracy of FACS based scATAC-seq. In
order to evaluate the precision of FACS sorting, we used a mix-
ture of two cell types of different sizes and species (“barnyard
experiment”): GM12878 human lymphoblastoid cell line (LCL)
and V6.5 mouse embryonic stem cells (ESCs). Of note, the size
difference between these two cell types is not a concern in the
FACS-based scATAC-seq method, whereas the C1 microfluidics
system requires separation into two size-restricted integrated
microfluidic chips. First, both mouse ESC (mESCs, n= 144) and
human LCL (n= 144) were fixed with 1% formaldehyde and
mixed in a 1:1 ratio. Then ATAC was performed in bulk. Next,
we sorted single cells from the mixture of cells by FACS without
regard to cell type, and collected individual cells in 96-well plates
containing the new reverse crosslinking buffer. After reverse
crosslinking, library preparation and sequencing (Methods), all
fragments were aligned to mouse and human genomes. Indeed,
we found that each individual well contained predominantly
either human or mouse DNA sequences, using a 500 fragment
cutoff and 96% species specificity (0 hybrid out of 288 cells,
Fig. 1b, Methods), confirming the precision of our index FACS
sorting.
To assess the single-cell Pi-ATAC library quality, we prepared
libraries from 192 GM17878 cells and comprehensively compared
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those with bulk GM12878 ATAC-seq datasets (n= 4). Single cells
that produced low-quality data were excluded from downstream
analysis using nuclear fragment amount and fraction of reads in
accessible chromatin peaks, as previously described12. Of the 192
GM12878 cells, 168 (87.5%) passed filter (Supplementary
Figure 2a, Methods). Aggregation of these 168 single cells shows
comparable accessibility patterns as bulk ATAC-seq (Supple-
mentary Figure 2b, Supplementary Figure 2c R= 0.81 for 77,855
peaks, p < 0.00001). We then measured TF variation scores in
GM12878 Pi-ATAC data, using the computational tool Chrom-
Var12 (Methods). The most significant variable TF motif was
Nuclear Factor Kappa B (NF-κB) family (Supplementary
Figure 2d), which agrees with previous scATAC-seq data from
the same cell line3.
Next, we compared Pi-ATAC data with publically available
scATAC-seq data3. GM12878 Pi-ATAC and GM12878 scATAC-
seq data yielded similar profiles of genome-wide accessibility (R=
0.8 for 77,855 peaks, p < 0.00001 Supplementary Figure 2e) as well
as overall TF motif variability (R= 0.7 for 384 motifs, p < 0.00001
Supplementary Figure 2f). To ensure that antibody staining of
extra- or intracellular proteins does not interfere with the quality of
Pi-ATAC, 384 GM12878 cells were stained against the B-cell
surface marker CD19 and intracellular phosphorylated NF-κB
(Supplementary Figure 2g). The antibody staining did not
substantially affect the quality of Pi-ATAC, with 298 cells (77.6%)
passing filter (Supplementary Figure 2h). The stained GM12878 Pi-
ATAC data share concordance with previously published GM12878
scATAC-seq data in accessibility of peaks (R= 0.72 for 77,855
peaks, p < 0.00001 Supplementary Figure 2i), in the genomic
annotation of peak distribution (Supplementary Figure 2j) and in
TF motif accessibility at NF-κB and Jun motifs (Supplementary
Figure 2k). Aggregation of these 298 single cells shows comparable
accessibility patterns as bulk ATAC-seq (Fig. 1c). We next
compared our GM12878 Pi-ATAC data with available scATAC-
seq data across multiple cell types3. Two-dimensional t-distributed
stochastic neighbor embedding (t-SNE) projection based on TF
motif accessibility revealed clustering of single cells largely
according to cell type, demonstrating Pi-ATAC GM12878 clusters
together with the published scATAC-seq GM12878 data and
distinct from other cell types (Supplementary Figure 2l).
We next quantified the information content provided by
single cells in Pi-ATAC. Sparse DNA accessibility data from an
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Fig. 1 Principle of protein-indexed single-cell ATAC-seq (Pi-ATAC). a The workflow of Pi-ATAC. b The precision of single-cell FACS sorting demonstrated
by aligned fragment comparison of mouse (mESC, blue) and human (GM12878, red) 1:1 cell mixture, using a 96% species and 500 fragment cutoff.
c UCSC genome browser track comparison of aggregated 298 single-cell Pi-ATAC to bulk ATAC-seq (both GM12878). d Pearson correlation of fragment
counts in ATAC-seq peaks in bulk GM12878 ATAC-seq data compared with aggregated single cells from indicated single-cell ATAC-seq approaches and
mimic single cells from bulk (shown are distribution of 1000 times simulation on down sampling 500 fragments from each randomly selected single-cell or
bulk sample)
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individual cell suffice to infer TF motif activity, based on the
summed accessibility of DNA elements containing the TF motif
vs. background elements, as previously reported for scATAC-
seq12 (Supplementary Figure 2d, l). We find that data
aggregation from 50 or more single cells by Pi-ATAC correlated
significantly with bulk ATAC-seq on peak accessibility
quantifications (Pearson correlation R= 0.615 for 77,857 peaks
in 50 cells, R= 0.694 in 100 cells, p < 0.0001, false discovery rate
(FDR) < 0.01, Fig. 1d, Methods). This observation is controlled
for cell-to-cell variance and sequencing depth artifacts, as
determined by 1000 simulation runs of subsampling equalized
contribution of 500 fragments in peaks per single-cell from a
randomly selected 50 cells subset. The same analysis produced
similar results in protein epitope-stained Pi-ATAC data vs.
published GM12878 scATAC-seq data3. Similar results are
obtained by down sampling to 500 fragments in peaks from
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Fig. 2 Pi-ATAC precisely dissects the cell types based on epigenetic profile. a FACS sorting gating strategy and data of EpCAM+ and CD45+ cells from
mixture of 4T1 cells and mouse splenocytes; the histogram of protein staining is presented in Supplementary Figure 4a. b Genome browser tracks of
aggregated Pi-ATAC 4T1 (EpCAM+) (n= 95) and splenocytes (CD45+) (n= 95) at the Epcam and Cd45 loci. c t-SNE projection generated from TF
deviation z-scores showing the projection of chromatin accessibility from Pi-ATAC 4T1 (EpCAM+) (n= 95) and splenocytes (CD45+) (n= 95).
d Heatmap of unsupervised hierarchical clustering of the 30 top variable TF deviations from 4T1 (EpCAM+) (n= 95) and splenocytes (CD45+) (n= 95)
Pi-ATAC. Each column represents a cell and each row a motif. The staining cluster information from FACS was assigned to each individual cell (top color
bar)
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bulk ATAC-seq data to mimic single-cell data (“mimic from
bulk” in Fig. 1d, Methods).
Together, these results indicate that Pi-ATAC captures cell–cell
variation in active regulatory DNA, as well as previous published
scATAC-seq protocols while providing protein epitope measure-
ments. With appropriate cell lineage and cell state characteriza-
tion, Pi-ATAC data from appropriate single cells can be
aggregated to reproduce a “pseudo-bulk” genomic DNA acces-
sibility profile.
Pi-ATAC probes TF protein abundance vs. DNA motif access.
The K562 chronic myeloid leukemia (CML) cell line is a het-
erogeneous cell mixture containing both precursor and differ-
entiated cells13. Several key TFs such as GATA1, GATA2, or
TAL1 regulate hematopoietic precursor status14,15. Along with
others, we demonstrated that the self-renewal and multipotency
of K562 cells is correlated with high expression level of
GATA216,17. It is unclear whether GATA2 is a pioneer factor in
this context, i.e., creating the first DNA access at its cognate
motif, or follows other TFs by accessing DNA elements occupied
by other TFs. Therefore, we applied Pi-ATAC to K562 cells using
GATA2 staining to measure the epigenetic status and hetero-
geneity of the precursor cells within the K562 population
(Methods). To focus only on the nuclear presence of GATA2, we
isolated the K562 nuclei to exclude cytoplasmic GATA2, as well
as mitochondria contamination.
As expected, GATA2 staining intensity in K562 nuclei is
variable, ranging from 1 to 8400 relative fluorescence units ,
clearly clustering into three groups, which we categorized as high,
medium, and low (Supplementary Figure 3a). Of the 288 nuclei
sorted, 223 (77.4%) passed the filter (Supplementary Figure 3b).
In line with previous scATAC-seq results3, our Pi-ATAC results
display highest variability in the motif accessibility of the GATA
and Jun/FOS family (Supplementary Figure 3c, d, Methods).
Surprisingly, we did not find a significant correlation between
accessibility of GATA2 motif itself with GATA2 staining
(Supplementary Figure 3e), but we observed significant positive
correlations of GATA2 protein level with accessibility of other TF
motifs, including TAL1::TCF3 (R= 0.21), MTF1 (R= 0.19),
CEBPA (R= 0.12), GSC (R= 0.15), SRF(R= 0.16), and DUX(R
= 0.26, all with p < 0.05 and FDR < 5%), which are involved in
maintaining hematopoietic cells in a de-differentiated cell
state14,15,18–20 and determining hematopoietic cell fate in multi-
potential progenitor cells21 (Supplementary Figure 3e). TAL1,
TCF3, and MTF1 have been reported to be potential binding
partners in larger protein complexes with GATA222,23. At the
same time, we also observed that the accessibility of TFAP motif
is significantly anti-correlated with GATA2 stain (R= –0.2, p <
0.05) (Supplementary Figure 3e). TFAP was previously reported
to drive hematopoietic differentiation24, the opposite role of
GATA2 in CML cells. Based on direct quantification of
nuclear GATA2 protein and chromatin access from the same
cell, our results suggest that GATA2 cooperates with other TFs
such as TAL1 and MTF1 to promote CML cell self-renewal in
K562 cells.
Our findings suggest the feasibility to use Pi-ATAC to directly
probe TF mechanisms linking protein abundance, and DNA
accessibility.
Simultaneous Pi-ATAC of tumor cells and immune cells. We
next applied Pi-ATAC to primary tumor samples. Tumor tissue is
comprised of different cell types, including tumor, stromal, and
tumor-infiltrating immune cells, each with heterogeneous cell
sizes and cell surface markers. Therefore, we first tested Pi-ATAC
on an artificial mixture of mouse breast tumor cell line 4T1 and
mouse splenocytes for (i) the sort efficiency of cells with com-
parable size differences as occurring in the primary tumors, (ii)
lineage-specific antibodies, such as the mutually exclusive
expression of EpCAM in the breast cancer cells and CD45 in
splenocytes and tumor-infiltrating immune cells. As expected, the
mixture of breast cancer cells and splenocytes are clearly dis-
tinguished and sorted using EpCAM and CD45 antibodies
(Fig. 2a, Supplementary Figure 4a). We sorted 192 cells and
performed Pi-ATAC, of which 190 (99.0%) cells passed the filter
(Supplementary Figure 4b). Importantly, aggregated single cells
from EpCAM+ 4T1 and CD45+ splenocytes show cell type-
specific open chromatin at Epcam and Cd45 loci, respectively
(Fig. 2b), confirming the specificity of the antibodies and sorting.
Within the top 30 out of 278 significant variable TF motifs, we
observed two clusters of chromatin accessibility profiles specific
for 4T1 and splenocytes, respectively, Spic and Irf motifs in
immune cells and Nfi family motifs in 4T1 tumor cells (Fig. 2d).
Addition of the protein-staining information confirms the chro-
matin accessibility clustering and also reveals that three spleno-
cytes (1.5%) cluster with 4T1 cells (Fig. 2c, d). Together, these
results show the specificity and precision of Pi-ATAC approach
to deconvolute cell communities.
Pi-ATAC of breast tumor ecosystem. Cancer heterogeneity is a
major driver of tumor evolution, progression, and emergence of
drug resistance. Although cancer heterogeneity can be assessed
with recent advances in single-cell technologies, the focus lies
mainly on cell-to-cell transcriptional or mutational differences.
The heterogeneity of epigenetic information within a tumor,
particularly in solid tumors, is largely unexplored.
As a case study, we applied Pi-ATAC to the fast growing and
highly invasive MMTV-PyMT genetically engineered mouse
breast tumor model25 to simultaneously dissect EpCAM+ tumor
cells and tumor-infiltrating immune cells (CD45+) (Fig. 3a,
Methods). We stained a single-cell suspension of the dissected
tumor with anti-EpCAM and anti-CD45 as above and performed
Pi-ATAC on 384 cells (Supplementary Figure 5a). We did not
exclude any tumor regions or cells, obtaining an unbiased view of
the composition of the tumor. Of all stained cells 4% were
immune cells (CD45+), 28% were epithelial tumor cells (EpCAM
+) (Supplementary Figure 5a). The quality of Pi-ATAC in these
primary tumor cells isolated from a solid tumor was equivalent to
Pi-ATAC performed of any cell line with 369 (96.1%) cells
passing the filter (Supplementary Figure 5b). Aggregated single
cells from EpCAM+ and CD45+ cells show cell type-specific
open chromatin at Epcam and Cd45 loci, respectively (Supple-
mentary Figure 5c).
Surprisingly, although the distinction of the protein staining is
pronounced, the t-SNE projection of EpCAM+ cells and CD45+
cells of bias-corrected deviations for motifs did not form two
distinct clusters (Fig. 3b). However, the protein information aids
visualization of a polarity of the distribution of the EpCAM+
cells and immune cells and reveals mixing of the two cell types.
The previous observed clear separation of 4T1 and mouse
splenocyte epigenetic profiles excludes the possibility of antibody
cross-contamination.
We next calculated the variability of TF motifs across all
cells, resulting in 84 significant variable motifs (p < 0.05 after
Benjamini–Hochberg (BH) correction on multiple tests,
Supplementary Data 1). Unsupervised hierarchical clustering
of the 84 TF motifs across 369 cells revealed three modules of
motif accessibilities (28 motifs in m1, 14 in m2, and 42 in m3)
and seven subgroups of single cells (s1–s7 with cluster
size range from 27 to 68 cells) (Fig. 3c, d, Supplementary
Figure 5d, i). TF motifs of m1 consisting of immune
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-07115-y ARTICLE
NATURE COMMUNICATIONS |          (2018) 9:4590 | DOI: 10.1038/s41467-018-07115-y | www.nature.com/naturecommunications 5
cell-specific motif families (Spic, Runx, Ets, etc.) show uniform
accessibility among cells in s1 and s2 (Fig. 3c, e). M2 motifs,
including chromatin remodeling relevant TF motifs such as
Smarcc1, Jun, and Fos family are consistently accessible in cells
of s1 and s4 (Fig. 3c, f). M3 comprises TF motif families Hmga,
Hif, Nfi, Tead, p53, Grhl1, and Fox. We observed heterogeneity
across all cellular subgroups for TF motif accessibility in m3,
however, highest mean motif accessibility in s3, s4, and s6
(Fig. 3c, g, Supplementary Figure 6). Collectively, the seven
different cellular subgroups might reflect the heterogeneity of
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the composition of EpCAM+ tumor cells and CD45+ tumor-
infiltrating immune cells.
Next, we aligned the FACS protein-staining information to the
seven cellular subgroups (Fig. 3c, h). As expected, s1 and s2 are
significantly enriched with CD45+ cells (92.4% of 66 cells in s1
and 94.1% of 68 cells in s2, chi-squared test p < 0.0001 for others,
after BH correction of multiple tests, Supplementary Data 2). The
majority (102 out of 177 (57.6%)) of EpCAM+ cells fall into s3,
s4, and s7 (76.7% of 30 cells in s3, 88.2% of 68 cells in s4, and
90.7% of 43 cells in s7, enriched with EpCAM+ cells, chi-squared
test p < 0.0001 for others, after BH correction of multiple tests,
Supplementary Data 2). The remaining 75 of 177 EpCAM+ cells
are in s5 and s6 mixed together with CD45+ cells. EpCAM+
subgroups are characterized by accessibility of TF motifs in m3, a
module characterized by heterogeneous accessibility in various TF
motifs such as p53-, Tead-, Nfi-, and Hif-families. This
heterogeneous TF motif accessibility in m3 prevents clear
categorization of some cells, but the protein information guides
the classification into immune and tumor cells. Interestingly, m2
motifs associated with chromatin remodeling TFs, such as Smarcc
and Fos, show specific accessible in subgroups of both EPCAM+
(s1) and CD45+ (s4) cells (Fig. 3f), suggesting variable regulation
on different subgroups within each cell type. Our result shows
that Pi-ATAC dissects chromatin profile of different cell types
simultaneously from the primary tumor, and staining informa-
tion is necessary to unambiguously define the cell type from such
complex system.
We also performed an unbiased analysis of sequence features
associated with variation in chromatin accessibility across
tumor and immune cells. We searched for enrichment of short
nucleotide sequences of a specific length k in accessible regions
using ChromVAR. This k-mer analysis allows discovery of
novel motifs and is not restricted by any database entry.
Because most TF have core motifs between 5 and 8 bp, we use
6-, 7-, and 8 k-mer analysis to find enrichment of motifs of 8 or
less base pairs (Supplementary Data 3-5). The top enriched
(p-value < 0.05 after BH correction of multiple tests) k-mer
represents RUNX motif family, followed by TEAD, Jun-Fos,
and NFI families (Fig. 3c, Methods). As all of these k-mers are
already found using annotated TF motifs in CisBP database, we
decided to proceed using CisPB results for downstream TF
motif analysis.
Assuming the artificial mixture of immune and tumor cells
defines TF motif accessibility characteristic for these cell types, we
compared TF motif variability of 4T1 with splenocytes, and of
CD45+ tumor-infiltrating immune cells to EpCAM+ primary
tumor cells (Fig. 3i). Of the 84 significant variable TF motifs
across the primary cells, 49 are shared between the two datasets.
Of note, although the top 10 most variable motifs from the tumor
immune cell mixture experiment are all m2 motifs shared with
the primary cells, most of the heterogeneous TF motif
accessibility in m1 and m3 was not observed as significantly
variable in the cell line mixture. Thus, we next asked which TF
motifs are the main contributors to the heterogeneity in m3 and
m1 assuming that contributing TFs are unique features of in vivo
tumors. Motifs along the y axes stand out as having additional
variability of accessibility in tumor cells and infiltrating immune
cells compared with the artificial mixture (Fig. 3i). Of these
motifs, the most variable ones are defining m1 of the hierarchical
clustering (Fig. 3i, lavender dots). These results show that motifs
accessible in m1 are unique to the tumor-infiltrating immune
cells, because of their absence in the splenocytes. Although m1
motifs are accessible specifically in CD45+ cells, m3 accessibility
is biased towards EpCAM+ cells (Supplementary Figure 6).
Interestingly, the predominant TF motif specific to primary
tumor cells enriched in m3 is Hif (Fig. 3i, pink dots). We found
the Hif motif to be the most significant unique variable motif of
the heterogeneous m3 module (Fig. 3g). HIF protein stability is
tightly linked to the hypoxic environment26, thus we hypothesize
that the hypoxic microenvironment in a solid tumor may
modulate the chromatin accessibility and heterogeneity observed
in the primary tumor.
Hypoxia drives single-cell epigenetic variability in tumor
microenvironment. To directly demonstrate that the hypoxic
microenvironment influences the tumor epigenetic landscape
in vivo, we applied Pi-ATAC to EpCAM and HIF1α-stained cells
in the MMTV-PyMT breast tumor model. We isolated 956
EpCAM+ cells and observed 762 negative, 139 low, and 55 high
HIF1α protein-positive cells from the tumor (Fig. 4a). Among
these, 956 cells analyzed by Pi-ATAC, 839 passed the filter
(Supplementary Figure 7a).
Focusing first on the accessibility profiles, unsupervised
hierarchical clustering revealed two motif clusters and 20 cell
state subgroups (Supplementary Figure 8a–c). The first motif
cluster is dominated by high accessibility of motifs of the E26
transformation-specific (ETS) family, whereas the m2 is not
showing clusters of accessible motifs. The subdivision of all
EpCAM+ cells into 20 subgroups suggests high epigenetic
heterogeneity within the tumor cells. Interestingly, HIF1α
staining does not correlate with any specific cell cluster,
demonstrating that the protein information provides an ortho-
gonal measurement to the epigenetic profile.
The variability of TF motif accessibility profiles across the three
HIF-staining groups is substantially different (Fig. 4b, Supple-
mentary Data 6). This difference is not due to the variable sample
size of the HIF-staining groups as demonstrated by down
sampling simulations (Supplementary Figure 7b, Supplementary
Data 6). The variability of TF motif accessibility is the highest
among cells not experiencing hypoxia, which are also the majority
of cells in the population (Fig. 4b, Supplementary Figure 7b).
Among the strongest variable motifs in the negative HIF1α group
Fig. 3 Pi-ATAC dissects EpCAM+ tumor cells and tumor-infiltrating immune cells from the same mouse breast tumor. a Schematic illustrating the different
cell types in the mouse breast tumor. b t-SNE projection of TF deviation z-scores of Pi-ATAC EpCAM+ (n= 177) and CD45+ (n= 192) cells from the
same mouse breast tumor. c Unsupervised hierarchical clustering of the TF deviation z-scores of all 84 significant variable TFs (p < 0.05 after
Benjamini–Hochberg (BH) correction on multiple tests) across EpCAM+ (n= 177) and CD45+ (n= 192) cells from the same mouse breast tumor. Each
column represents one cell and each row a transcription factor motif. Motif modules (m1–3) and cell subgroups (s1–7) are marked with distinguished
colors. In addition, the staining cluster information from FACS was assigned to each individual cell (top color bar). d t-SNE projection of TF deviations of
84 significant variable TF motifs of EpCAM+ and CD45+ cells isolated from a tumor, color coded by cellular subgroup information; e-g color coded by the
accessibility of the TF motif with most significant variability in each module (Fig. 3d): Ets2 in m3 (e), Smarcc1 in m2 (f) and Hif in m1 (g). Motifs are based
on PWM from CisBP database. Red is highly accessible, blue is low accessible; h color coded by immune-phenotype. i Scatter plot of TF motif variability
calculated by ChromVAR across 4T1–splenocyte mixture to TF variability calculated by ChromVAR across EpCAM+ – CD45+ primary tumor cells. Colors
indicate TF motif modules as in (c). Arrow points to Hif
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are Fos, Smarcc1, and Batf, which were observed to be accessible
in a subgroup of EpCAM+ cells in the previous experiment. The
variability of low and high HIF1α is dominated by p53 TF family
motifs. Hypoxia is known to increase p53-protein levels via
several mechanisms, which may be reflected in TF motif
activity27. Additional TF motifs that are highly variable in
hypoxic cells include Grainyhead and Snail, TFs involved in
epithelial–mesenchymal transition and known mediator of breast
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Fig. 4 Epigenetic variability is modulated by the hypoxic microenvironment. a FACS sorted EpCAM+ and HIF1α+ double-positive cells from the same
mouse breast tumor; three groups of HIF1α staining were assigned, HIF1α negative (n= 762), HIF1α low (n= 139), HIF1α high (n= 55) (right plot).
b Ranking of transcription factor motif variability of different HIF1α-staining groups, HIF1α negative (n= 702), HIF1α low (n= 95), HIF1α high (n= 42).
c Examples of TF motif deviations, which significantly change in HIF1α high group compared with the others. In each comparison, HIF1α negative (n= 702),
HIF1α low (n= 95), HIF1α high (n= 42). Significance of Wilcoxon test shown with n.s. (not significant), *p < 0.05 and **p < 0.01. d Flow cytometry analysis
of HIF1α protein abundance in 4T1 breast cancer cells cultured in 5% oxygen (Ctrl, gray) or 1% oxygen for indicated time points. e Chromatin accessibility
changes of hypoxic conditions compared with control. Red indicates higher, blue lower accessibility. f TF deviation examples of motifs whose accessibility
increases in hypoxia over time in 4T1 breast cancer cells (TF deviation was calculated using ChromVAR)
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cancer metastasis28,29 and might reflect the evading mechanism
observed in hypoxic cells27.
Fox and E2f3 were previously reported to be regulating
transcription of HIF target genes30,31. Indeed, the tumor Pi-
ATAC data demonstrate a significant increase of DNA accessi-
bility of motifs for Fox family and E2f3 in the cells with high
HIF1α protein (Wilcoxon test p < 0.05, Fig. 4c) in a more detailed
comparison of TF motif accessibility across the three groups. At
the same time, we observed TF motifs of Pit1 and Atoh8 lost
significant DNA accessibility (Wilcoxon test p < 0.05) in cells with
high HIF1α protein (Supplementary Figure 9). Atoh8 expression
was reported to be reduced in hypoxic conditions32. Pit1 is an
important developmental factor33 associated with cancer but not
previously associated to be regulated by the HIF network.
Surprisingly, we found on average decreased accessibility at
HIF motifs in HIF1α high cells compared with negative and low
(Fig. 4c, Wilcoxon test p < 0.05). However, we also observe a
bimodal distribution of HIF motif accessibility within this HIF1α
high group (Fig. 4c, p < 0.05 for Hartigans’ dip statistic). This
feature is not due to variable sample size across the three staining
groups, as shown by down sampling simulation in negative and
low HIF1α clusters to the same number of cells as found in the
HIF1α high group (n= 42) (Supplementary Figure 10, Supple-
mentary Data 7). This bimodality shows heterogeneity in HIF
motif accessibility, which might reflect distance to the hypoxic
center or time of hypoxia exposure.
By organizing single cells based on HIF1α protein levels, we
now can interpret a subset of DNA accessibility dynamics that
likely reflect the hypoxic microenvironment modulating coop-
erating TFs acting on target gene promoters and enhancers.
To confirm if the DNA accessibilities of tumor cells,
particularly HIF, Fox, E2f3, Atoh, Pit1 motifs, are indeed
modulated by hypoxia and no other tumor microenvironmental
stimuli, we used an in vitro cell line culture system to simulate the
in vivo hypoxia microenvironment. We incubated the mouse
breast tumor cell line 4T1 in 1% O2 for various time points (6, 12,
24, 36, 48, and 72 h). To avoid the degradation of HIF proteins
under normoxia, we fixed and collected cells in 1% O2 followed
by HIF1α protein staining and standard bulk ATAC-seq at the
indicated time points. Increased HIF protein stability was then
measured by flow cytometric analysis (Fig. 4d). We observe an
increase in HIF1α staining, confirming that the 4T1 cells
experienced bona fide hypoxia.
All bulk ATAC-seq libraries have good reproducibility at all
the time points (Supplementary Figure 11a–c). We observe
changes in the chromatin accessibility across time in low oxygen,
with 635 at 6 h to over 1000 sites opening at 72 h compared with
normoxic cells. Interestingly, only a small number of DNA
elements (~20–70) lose DNA access during this treatment
(Fig. 4e). These differential accessible chromatin sites were
annotated to 755 significantly differential accessible TF motifs,
using the CisBP database (Supplementary Figure 11d, Supple-
mentary Data 8, Methods).
This reference time course allowed us to next focus on the
dynamic changes of TF motifs, which we assume to be involved in
hypoxic responses of tumor cells, because they are enriched in
HIF1α high group in the Pi-ATAC tumor experiment (Fig. 4c).
Indeed, we found that the chromatin accessibilities are affected at
HIF, Fox, E2f3, Ptx1, and Atoh8 motifs during the different time
points of hypoxia incubation (Fig. 4f, Supplementary Figure 12).
Also in vitro HIF motif accessibility undergoes dynamic changes,
showing both decrease and then increase at different time points
of hypoxia treatment confirming the slight decrease and
variability observed in vivo. Foxp1 and E2f3 motif gain DNA
accessibility with increasing duration of hypoxia incubation
(Fig. 4f). At the same time, accessibility of Pit1 and Atoh8 motifs
decrease with longer hypoxia incubation, both results confirming
the accessibility differences observed in HIF1α high vs. negative
group in vivo (Supplementary Figure 12).
In summary, Pi-ATAC is the first technique that allows directly
linking the microenvironment to epigenetic heterogeneity in a
tumor.
Discussion
Here, we develop a novel single-cell technology, Pi-ATAC, which
simultaneously measures protein epitopes and active DNA reg-
ulatory elements of the same individual cell. Pi-ATAC enables
investigation of the basic molecular mechanism of cellular het-
erogeneity from multiple angles.
Pi-ATAC directly links the cellular phenotype or micro-
environment to the epigenetic profile, because it uses antibody
staining and index FACS sorting to combine protein abundance
information with the epigenetic profile of a cell. Powerful appli-
cations are exemplified by our experiments quantifying the pro-
tein levels of TFs NF-kB and HIF1α, both regulated by intricate
post-translational modification, and measuring their DNA
occupancy at the same time. Furthermore, we demonstrate that
Pi-ATAC is applicable to both fixed cells from cultured cells and
solid tumors in vivo, without any cell size restrictions.
In Pi-ATAC, choice of antibodies allows to combine pheno-
typic characterization of cells with their epigenetic profile. Pi-
ATAC can directly link protein abundance or modifications with
chromatin landscape to address mechanisms of gene regulation.
We demonstrate that the epigenetic profile does not necessarily
have a one-to-one relationship with the “phenotype” indicated by
protein stain, demonstrating that both together give a more
complete picture of cell state than either one alone. The impact of
this precision analysis is highlighted in our analysis of tumor
hypoxia, where the intermediate level of HIF1 protein induction
is linked to tumor suppression pathway.
The tumor microenvironment has been recognized as an
integral component of malignancies in mammary and other
carcinomas, contributing in confounding ways to tumor pro-
gression, metastasis, therapy resistance, and disease recurrence34.
In the tumor microenvironment, immune cells change from an
immune-active to an immune-suppressive state, stromal cells turn
into tumor-promoting tissue. The altered phenotype of these cells
is proposed to be mainly due to epigenetic deregulation of gene
expression;35 however, until now, a direct measurement linking
the microenvironment with epigenetic changes does not exist.
These epigenetic changes are highly dynamic, causing hetero-
geneity of cell states within a tumor, which contributes to drug
resistance, and tumor recurrence36. By directly linking the
environment with HIF1α protein accumulation and the chro-
matin profiles of single cells, we show that tumor hypoxia
dominantly shapes the regulome profiles of both parenchymal
tumor cells and infiltrating immune cells, becoming the dominant
epigenomic signature for a minority of cells in the tumor.
Moreover, different levels or durations of hypoxia can induce
distinct TF activity states that expand tumor heterogeneity. The
biological insight of this new technique will be of great value for
single-cell research in future.
In summary, Pi-ATAC is easily scalable, fast and economical
(~$0.15 per cell–$1.50 per cell, Methods). Pi-ATAC is high
throughput and easily scalable; with sorting into 384-well plates
and use of 96 × 90 adapter combinations to index 8640 single cells
in one experiment. Importantly, Pi-ATAC can be performed
without any specialized instrument or reagents, allowing ready
access to the broad community. Pi-ATAC may be useful to
address potential prognostic and therapeutic opportunities
revealed by these insights in future studies.
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Methods
Cell culture. GM12878 were purchased from Coriell Institute and grown in RPMI-
1640 (11875-093, Gibco), 2 mM L-glutamine (25030-081, Gibco), 15% fetal bovine
serum (FBS, 07905, Gibco), and 1% Pen/Strep (15140-122, Gibco). 4T1 mouse
breast cancer cells were purchased by ATCC (CRL-2539) and cultured in RPMI-
1640 supplemented with 10% FBS (07905, Gibco) and 1% Pen/Strep (15140-122,
Gibco). K562 human CML cells were purchased from ATCC (CCL-243) and
cultured in Iscove's Modified Dulbecco's Media supplemented with 10% FBS
(07905, Gibco) and 1% Pen/Strep. V6.5 mESCs (Novus Biologicals) were cultured
in Dulbecco’s modified Eagle’s medium/F12 supplemented with N2, 10 ng/ml basic
fibroblast growth factor (R&D Systems), and 1000 U/ml of Leukemia inhibitory
factor (LIF). For the 4T1 in vitro hypoxia experiments, cell lines were cultured in a
Ruskinn Invivo2 workstation maintained at 1% O2 and 5% CO2, and cells were
collected with trypsin digestion in the Ruskinn Invivo2 workstation and fixed
immediately after 6, 12, 24, 36, 48 and 72-h incubation.
Mice. MMTV-PyMT mice were ordered from the Jackson Laboratory and bred
and housed in the Stanford University Research Animal Facility in accordance with
the guidelines (APLAC #14046). The laboratory animal care program at Stanford is
accredited by the Association for the Assessment and Accreditation of Laboratory
Animal Care (AAALAC International).
Splenocyte isolation. A spleen was dissected from a MMTV-PyMT mouse, which
did not have a tumor at the time of euthanization. Then, the spleen was sliced into
small pieces. Single cells were isolated from these pieces by placing them onto a 70
µm cell strainer and mechanically pushing the cells with a plunger through the
strainer. Red blood cells were permeabilized using ACK buffer (Thermo Fisher,
A1049201). After washing cells twice with RPMI-1640 medium, cells were counted
and used in the 4T1–splenocyte mixture Pi-ATAC experiment.
Mouse breast tumor dissection and dissociation. Tumor growth has been
monitored and mice were sacrificed at 3 month of age, when tumors reached a 1
cm3 size. The mouse was immediately perfused using 4% PFA, which was subse-
quently quenched with 0.125M glycine. The tumor was dissected and first cut into
small pieces on ice, followed by enzymatic digestion using 200 U Collagenase V in
Hanks' Balanced Salt Solution (HBSS)+ 0.1% FBS for 1 h at 37 °C rotating. After
centrifugation cells were resuspended in PBS and this suspension was filtered
through a 70 µm cell strainer to remove any remaining clumps. Cells can be stored
in phosphate-buffered saline (PBS) for at least 1 week at 4 °C.
Bulk ATAC-Seq. Fixed ATAC-seq was performed as previously described10.
GM12878 cells were fixed with 1% formaldehyde (Sigma, USA) for 10 min and
quenched with 0.125 M glycine for 5 min at room temperature. After the fixation,
cells were counted and 50,000 cells were used per ATAC-seq reaction. The
transposition reaction follows the normal ATAC-seq protocol. After the transpo-
sition, a reverse crosslink solution (final concentration of 50 mM Tris-Cl, 1 mM
EDTA, 1% SDS, 0.2 M NaCl, 5 ng/ml proteinase K) was added up to 200 µl. The
mixture was incubated at 65 °C with 1200 rpm shaking in a heat block overnight,
then purified with Qiagen Mini-purification kit and eluted in 10 µl Qiagen EB
elution buffer. Sequencing libraries were prepared following the original ATAC-seq
protocol37. The sequencing was performed on Illumina Hi-Seq at the Stanford
Functional Genomics Facility.
Bulk Pi-ATAC-seq without elution. GM12878 cells were fixed with 1% for-
maldehyde (Sigma, USA) for 10 min and quenched with 0.125 M glycine for 5 min
at room temperature. After the fixation, cells were counted and 50,000 cells were
used per ATAC-seq reaction. For bulk Pi-ATAC of 4T1 cells, cells were first fixed
in hypoxia, then counted and permeabilized, followed by transposition. The
transposition reaction is the same as for standard ATAC-seq except with 0.05%
Igepal CA-630 in the lysis buffer. After 30-min transposition, at 37 °C, the reaction
was quenched using 40 mM EDTA, then cells were centrifuged and supernatant
was discarded. In all, 20 µl of reverse crosslinking solution was added to the cell
pellet (with final concentration of 50 mM Tris-HCl pH 8.0, 0.5% Tween 20, 0.5%
Igepal CA-630, 5 ng/ml proteinase K). Reverse crosslinking was performed 65 °C
overnight and inactivated by a 10-min incubation at 80 °C the next day. The 25 µl
PCR master mix (NEB, M0541S) and 5 µl of two unique primer combinations were
directly added to the reverse crosslinking mixture and PCR was performed as
previously described37. The PCR product was purified with Qiagen MinElute
purification kit and eluted in 20 µl Qiagen EB elution buffer. The 75 × 2 paired-end
sequencing was performed on Illumina HiSeq4000 at the Stanford Functional
Genomics Facility.
Pi-ATAC of mixture of GM12878 and mES cells. In all, 50,000 GM12878 and
50,000 mESCs were mixed 1:1. The mixture was fixed with 1% formaldehyde
(Sigma, USA) for 10 min and quenched with 0.125 M glycine for 5 min at room
temperature. Then, cells were permeabilized using standard ATAC lysis buffer (10
mM Tris ph7.5, 10 mM NaCl, 3 mM MgCl2, fresh 0.1% NP40) and immediately
spun down. Cells were then transposed in bulk; for 100,000 cells 2× ATAC
reactions were calculated. After 30-min tagmentation, reaction was quenched by
addition of 40 mM EDTA. Cells were centrifuged, supernatant discarded, and pellet
resuspended in PBS for single-cell index sorting. In the analysis, all alignments
below 500 fragments were disregarded.
Pi-ATAC of mixture of 4T1 cells and splenocytes. In total, 50,000 4T1 and
50,000 splenocytes were mixed 1:1. The mixture was fixed with 1% formaldehyde
(Sigma, USA) for 10 min and quenched with 0.125M glycine for 5 min at room
temperature. Then, cells were permeabilized using standard ATAC lysis buffer (10
mM Tris ph7.5, 10 mM NaCl, 3 mM MgCl2, fresh 0.1% NP40) and immediately
spun down. Cells were then transposed in bulk; for 100,000 cells 2× ATAC reac-
tions were calculated. After 30-min tagmentation, reaction was quenched by
addition of 40 mM EDTA. After that, cells were stained at room temperature with
anti-mouse EpCAM-BV421 (BD Horizon, #563214) CD45-Alexa488 (BioLegend
#103122, clone 30-F11) for 30 min. Cells were then washed twice, the final pellet
resuspended in PBS for single-cell index sorting.
Pi-ATAC of GM12878 cells. A detailed step-by-step Pi-ATAC protocol can be found
at [https://www.protocols.io/private/F59D7D2F8FD5E57A20E039E9CF7A9785].
GM12878 cells were counted and 100,000 cells were fixed with 1% formaldehyde
(Sigma, USA) for 10 min and quenched with 0.125M glycine for 5 min at room
temperature. Then, cells were permeabilized using standard ATAC lysis buffer (10
mM Tris ph7.5, 10 mM NaCl, 3 mM MgCl2, fresh 0.1% NP40) and immediately
spun down. For indicated experiments, 100,000 cells were then stained at room
temperature with anti-human CD19-PE Clone H1B19 (BioLegend 302207) and
rabbit anti-human Phospho-NF-kB p65 (Ser536, Cell Signaling) followed by donkey
anti-rabbit 488 secondary antibody. After staining (30min each antibody), cells
were transposed in bulk; for 100,000 cells 2× ATAC reactions were calculated. After
30-min tagmentation, reaction was quenched by addition of 40mM EDTA. Cells
were centrifuged, supernatant discarded, and pellet resuspended in PBS for single-
cell index sorting.
Index sorting and library preparation for Pi-ATAC. Single cells were index
sorted into 96-well plates without any specific staining selection using the FACS
AriaII (BD Biosciences). The plates were pre-filled with 20 µl reverse crosslinking
buffer (see above) per well. For each experiment, index sort files (fcs) were exported
using BD FACS Software and then further analyzed by FlowJo and R.
For reverse crosslinking, all 96-well plates were incubated overnight at 65 °C,
then proteinase K was inactivated by 10-min incubation at 80 °C.
Single-cell libraries were prepared by adding 25 µl 2 × PCR Master Mix
(NEBNext High fidelity, NEB) and 2.5 µl of 25 mM barcoding primer to each well.
PCR cycling conditions: 72 °C for 5 min; 98 °C for 30 s; 20 cycles at 98 °C for 10 s,
63 °C for 30 s, and 72 °C for 1 min. After that, all wells were pooled, purified using
the MinElute kit from Qiagen and eluted in 20 µl Qiagen EB elution buffer. The
75 × 2 paired-end sequencing was performed on Illumina HiSeq4000 at the
Stanford Functional Genomics Facility. On average, we sequenced ~1000 single
cells on one HiSeq 4000 lane, resulting in an average of ~0.3 millions reads per cell.
Pi-ATAC of K562 cells. First, we isolated the K562 nuclei by following the protocol
as reported38. For the Pi-ATAC, 200,000 nuclei were transposed; for 100,000 nuclei
2× ATAC reactions were calculated. After 30-min tagmentation, reaction was
quenched by addition of 40 mM EDTA. After that, cells were stained at room
temperature with mouse anti-human GATA2 (Abnova, 1-102) 30 min at room
temperature, followed by donkey anti-mouse 488 secondary antibody. Cells were
then washed twice, the final pellet resuspended in PBS for single-cell index sorting.
Pi-ATAC of tumor cells. In all, 1×106 cells isolated from a PyMT mouse breast
tumor (see above) were stained for 30 min at room temperature for rat anti-mouse
EpCAM-BV421 (BD Horizon, #563214), HIF1α-PE (R&D, #IC1935P), CD45-
Alexa488 (BioLegend #103122, clone 30-F11), followed by donkey anti-rabbit
488 secondary antibody. After staining, cells were transposed in bulk. Here, for
4000 final cells we tagmented 400,000 cells, meaning 8× ATAC reactions were
calculated. After 30-min tagmentation, reaction was quenched by addition of 40
mM EDTA. Cells were centrifuged, supernatant discarded, and pellet resuspended
in PBS for single-cell index sorting.
Single cells were index sorted into 96-well plates without any specific staining
selection using the FACS AriaII (BD Biosciences). The plates were pre-filled with
20 µl reverse crosslinking buffer (see above) per well. For each experiment, index
sort files (fcs) were exported using BD FACS Software and then further analyzed by
FlowJo and R.
For reverse crosslinking all 96-well plates were incubated overnight at 65 °C,
then proteinase K was inactivated by 10-min incubation at 80 °C.
Single-cell libraries were prepared by adding 25 µl 2 × PCR Master Mix
(NEBNext High fidelity, NEB) and 5 µl of two unique primer combinations, the
PCR cycling conditions: 72 °C for 5 min; 98 °C for 30 s; 20 cycles at 98 °C for 10 s,
63 °C for 30 s, and 72 °C for 1 min. After that, all wells were pooled, purified using
the MinElute kit from Qiagen and eluted in 20 µl Qiagen EB elution buffer.
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Pi-ATAC library purification, quantification, and sequencing. The pooled single-cell
Pi-ATAC libraries were loaded on a 6% polyacrylamide gel electrophoresis, run at
160 V for approximately 10-min purification, stain the gel with SYBR Gold. One
0.5 ml tube was prepared for one sample, and a hole was made in the bottom of 0.5
ml tube with 20 gauge needle. The gel slice with range of above 150-bp DNA were
cut and put in the 0.5 ml (with a hole in the bottom). Next, the 0.5 ml tube is put in
the 2 ml tube and centrifuged with max speed for 3 min at room temperature. After
removing the 0.5 ml tubes, 300 µl buffer (500 mM NaCl, 1 mM EDTA, 0.5% SDS)
was added in the gel. The gel is incubated at 55 °C overnight with 1400 rpm
shaking. Next day, the gel is centrifuged with max speed for 3 min at room tem-
perature, and the supernatant is recovered for DNA purification with ChIP DNA
Clean & Concentrator Kits (ZYMO RESEARCH, D5205). The recovered DNA is
quantified with Agilent High Sensitivity DNA ChIP and sequenced on Illumina Hi-
Seq at Stanford Functional Genomics Facility.
Pi-ATAC cost per cell. For Pi-ATAC, reagent costs is largely driven by the PCR
master mix. Cost estimate per cell: Tn5 enzyme (Illumina, $0.00049 per cell,
assuming 2.5 µl Tn5 per 50,000 cells), NEBNext® High-Fidelity 2X PCR Master
Mix (NEB, M0541) and primers (~$1.30 per cell) and negligible costs for antibodies
per cell (about $3 per protein per 106 cells). In summary, it costs about $1.50
per cell with 50 µl PCR reaction system. In addition, we had succeeded with
low-scale volume PCR reaction system at 5 µl per well of a 96-well plate, where the
cost is ~$0.15 per cell.
Bulk Pi-ATAC data preprocessing. Paired-end reads were trimmed for Illumina
adapter sequences and transposase sequences using custom-written script and
mapped to hg19 or mm9, respectively, using Bowtie239 v2.1.0 with parameters
—“very sensitive”. Reads were subsequently filtered for alignment quality of > Q30
and were required to be properly paired. Duplicate reads were removed with Picard
(http://picard.sourceforge.net) v1.79. Reads mapping to the mitochondria were
removed and not considered. The uniquely mapped reads are merged before peak
calling if bulk samples origin from the same cell/tissue/condition. Peak calling was
performed by MACS240 narrow peak mode with parameters –q 0.01 –nomodel
–shift 0. Peaks were filtered for following categories: (1) mitochondrial fragments
inserted in nuclear genomic sequences, by Nuclear MiTochondrial Sequences
(NumtS) [http://hgdownload.cse.ucsc.edu/goldenPath/hg19/database/ or http://
hgdownload.cse.ucsc.edu/goldenPath/mm9/database/] and (2) the consensus
excludable ENCODE blacklist genomic regions [http://mitra.stanford.edu/kundaje/
akundaje/release/blacklists/hg19-human/hg19-blacklist.xls or http://mitra.stanford.
edu/kundaje/akundaje/release/blacklists/mm9-mouse/mm9-blacklist.bed.gz].
To process comparison among bulk samples from multiple cell/tissue/
conditions, peak sets from all conditions were merged by bedtools merge to a
consensus peak list. Number of raw reads mapped to each peak in each sample was
quantified using multicov in Beltools. Peak raw counts were normalized using
DESeq2.
Pi-ATAC data processing. All single-cell Pi-ATAC data were preprocessed with
custom-written script as previously described3 and bulk preprocessed. Briefly, pair-
ended reads were trimmed with adapter sequences, were mapped to hg19 or mm9
with Bowtie2 v2.1.0 with parameter-X2000. Uniquely mapped reads were filtered
for low-quality reads, duplicates, and reads mapped to mitochondrial genome. Peak
summit calling was processed with aggregated single cells of one cell/tissue con-
dition, by MACS2 narrow peak mode with parameters –q 0.05 –nomodel –shift 0
–call summits. We annotated peaks as the summit-centered 500 base pair long
genomic region. The top 50,000 peaks with least q-value reported by MACS2 were
included for downstream analysis in most datasets; whereas top 30,000 peaks were
included for K562 dataset. Single-cell libraries were further filtered with require-
ment of at least 500 fragments mapped to genome and at least 0.5 times the median
proportion of fragments in peaks reached by aggregated single cells of the same
cell/tissue condition (ChromVAR)12.
Pi-ATAC data information content analysis. The quantification of fragments
mapped to each peak for the genomic DNA accessibility was compared between
bulk GM12878 Pi-ATAC samples and single-cell Pi-ATAC. Peak quantification of
bulk data was calculated as mean value of the four samples. Peak quantification of
Pi-ATAC was calculated for single cell, as well as for single cells aggregation in
group size 5, 10, 20, 50, 100, and 150. To adjust cell–cell variance, 1000 times of
simulation were processed to randomly select cells from the 192 GM cells into the
group. To adjust sequencing depth artifact, 500 of fragments passing the final filter
were randomly subsampled from the bam file for each cell in each time of simu-
lation. The same process was conducted for public scATAC-seq GM12878 data3.
We also generated 50 “mimic” single-cell data through down sampling 500 frag-
ments passing the final filter directly from each of the four bulk samples. Pearson
correlation coefficient with significance was calculated between peak quantification
of bulk and single-cell data from each approach.
TF deviation and variability analysis. Single-cell Pi-ATAC data processing and
calculation of TF deviation was performed using the R package ChromVAR as
reported12. TF motifs were derived from the JASPAR dataset for human data,
whereas Homer and CisBP databases were used for mouse data, with R package
motifmatchr. Briefly, for each TF, the accessibility in each cell was calculated by
subtracting the number of Pi-ATAC reads in peaks covering the corresponding
motif in the cell, and was normalized by the total TF accessibility in the cell. The
accessibility deviation value for the TF in each cell is subtracted by the mean
accessibility calculated for sets of background peaks with similar accessibility and
GC content to obtain a bias correction, and further divided by standard deviation
of the deviations calculated for the background peak sets.
TF deviation for the hypoxic time course bulk ATAC-seq was calculated using
the R package ChromVAR.
The Z-score of deviations for each TF is used for visualization in both t-SNE
projection plots and heatmaps of unsupervised hierarchical clustering based on
correlation metric, by R packages Rtsne and pheatmap.
The variability of the TF motif across single cells in the sample set was
determined by the standard deviation of the TF deviations across the cells. The
metrics is close to 1 if the motif is not significantly more variable compared with
the background peak list of that motif. To remove artifact of cell amount difference
among the three groups of mouse breast tumor assembled by HIF1α staining, 100
times of simulation were processed through down sampling 42 cells from HIF1α
low and HIF1α median group to re-calculate TF variabilities.
k-mer analysis. We performed an unbiased analysis of nucleotide sequence features
necessary for chromatin accessibility variation by searching for an enrichment of
short nucleotide sequences of a specific length k in accessible regions using
ChromVAR. This k-mer analysis allows discovery of novel motifs and is not
restricted by any database entry. Because most TF have core motifs between 5 and
8 bp, we use 6-, 7-, and 8 k-mer analysis to find enrichment of motifs of 8 or less
base pairs. K-mers with significant variability were assembled and searched against
multiple motif databases by Tomtom41 for either similarity to known motifs or
definition as a de novo motif.
Data availability
Raw and processed data were available at NCBI Gene Expression Omnibus,
accession number: GSE112091.
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